nach oben

Wiener klinische Wochenschrift

Erschienen in:

01.06.2017 | letter to the editors

Subacute cutaneous lupus erythematosus – paraneoplastic to gastric adenocarcinoma?

verfasst von: Maruška Marovt, Pij B. Marko

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 11-12/2017

Einloggen, um Zugang zu erhalten

Excerpt

Dear editors, …

Vorheriger Artikel Malignant mixed müllerian tumor mimicking cervical carcinoma

Nächster Artikel MedUni Wien Researcher of the Month Juni 2017

Walling HW, Sontheimer RD. Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol. 2009;10:365–81.CrossRefPubMed

Standholdt LH, Laurinaviciene R, Bygum A. Proton pump inhibitor-induced subacute cutaneous lupus erythematosus. Br J Dermatol. 2014;170:342–51.CrossRef

Brenner S, Golan H, Gat A, Bialy-Golan A. Paraneoplastic subacute cutaneous lupus erythematosus: report of a case associated with cancer of the lung. Dermatology. 1997;194:172–4.CrossRefPubMed

Chaundry SI, Murphy LA, White IR. Subacute cutaneous lupus erythematosus: a paraneoplastic dermatosis? Clin Exp Dermatol. 2005;30:655–8.CrossRef

Dawn G, Wainwright NJ. Association between subacute cutaneous lupus erythematosus and epidermoid carcinoma of the lungs: a paraneoplastic phenomenon? Clin Exp Dermatol. 2002;27:717–8.CrossRefPubMed

Ho C, Shumack SP, Morris D. Subacute cutaneous lupus erythematosus associated with hepatocellular carcinoma. Australas J Dermatol. 2001;42:110–3.CrossRefPubMed

Renner R, Sticherling M. Incidental cases of subacute cutaneous lupus erythematosus in association with malignancy. Eur J Dermatol. 2008;18:700–4.PubMed

Trueb RF, Trueb RM. Cutaneous paraneoplastic syndrome as an immunologic phenomenon exemplified by paraneoplastic subacute cutaneous lupus erythematosus. Praxis. 1999;88:1803–10.PubMed

Kuhn A, Kaufmann I. Subacute lupus erythematosus as a paraneoplastic syndrome. Z Hautkr. 1986;61(8):581–3.PubMed

Titel: Subacute cutaneous lupus erythematosus – paraneoplastic to gastric adenocarcinoma?
verfasst von: Maruška Marovt
Pij B. Marko
Publikationsdatum: 01.06.2017
Verlag: Springer Vienna
Erschienen in: Wiener klinische Wochenschrift / Ausgabe 11-12/2017
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI: https://doi.org/10.1007/s00508-017-1201-3

Springer Medizin Österreich

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11-12/2017

Dysregulated expression of homebox gene HOXA13 is correlated with the poor prognosis in bladder cancer

Evaluation of efficacy of alemtuzumab in 5 patients with aplastic anemia and/or myelodysplastic neoplasm

Veranstaltungen

Malignant mixed müllerian tumor mimicking cervical carcinoma

Active surveillance for low-risk prostate cancer in Austria: the online registry of the Qualitätspartnerschaft Urologie (QuapU)

Impact of gender on tumor stage and survival of upper urinary tract urothelial cancer